BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 18349569)

  • 21. Inflammation and development of pancreatic ductal adenocarcinoma.
    Shi J; Xue J
    Chin Clin Oncol; 2019 Apr; 8(2):19. PubMed ID: 31070039
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sonic hedgehog is an early developmental marker of intraductal papillary mucinous neoplasms: clinical implications of mRNA levels in pancreatic juice.
    Ohuchida K; Mizumoto K; Fujita H; Yamaguchi H; Konomi H; Nagai E; Yamaguchi K; Tsuneyoshi M; Tanaka M
    J Pathol; 2006 Sep; 210(1):42-8. PubMed ID: 16794990
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chemoprevention and Treatment of Pancreatic Cancer: Update and Review of the Literature.
    Benzel J; Fendrich V
    Digestion; 2018; 97(4):275-287. PubMed ID: 29587290
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inherited pancreatic cancer: improvements in our understanding of genetics and screening.
    Rulyak SJ; Brentnall TA
    Int J Biochem Cell Biol; 2004 Aug; 36(8):1386-92. PubMed ID: 15147717
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sirtuin-1 regulates acinar-to-ductal metaplasia and supports cancer cell viability in pancreatic cancer.
    Wauters E; Sanchez-Arévalo Lobo VJ; Pinho AV; Mawson A; Herranz D; Wu J; Cowley MJ; Colvin EK; Njicop EN; Sutherland RL; Liu T; Serrano M; Bouwens L; Real FX; Biankin AV; Rooman I
    Cancer Res; 2013 Apr; 73(7):2357-67. PubMed ID: 23370328
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pancreatic intraepithelial neoplasia in heterotopic pancreas: evidence for the progression model of pancreatic ductal adenocarcinoma.
    Zhang L; Sanderson SO; Lloyd RV; Smyrk TC
    Am J Surg Pathol; 2007 Aug; 31(8):1191-5. PubMed ID: 17667542
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevention of pancreatic cancer and strategies for management of familial pancreatic cancer.
    Hruban RH; Canto MI; Yeo CJ
    Dig Dis; 2001; 19(1):76-84. PubMed ID: 11385254
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Linc00675 is a novel marker of short survival and recurrence in patients with pancreatic ductal adenocarcinoma.
    Li DD; Fu ZQ; Lin Q; Zhou Y; Zhou QB; Li ZH; Tan LP; Chen RF; Liu YM
    World J Gastroenterol; 2015 Aug; 21(31):9348-57. PubMed ID: 26309360
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acinar-to-ductal metaplasia accompanies c-myc-induced exocrine pancreatic cancer progression in transgenic rodents.
    Grippo PJ; Sandgren EP
    Int J Cancer; 2012 Sep; 131(5):1243-8. PubMed ID: 22024988
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Familial Pancreatic Cancer and the Future of Directed Screening.
    Welinsky S; Lucas AL
    Gut Liver; 2017 Nov; 11(6):761-770. PubMed ID: 28609837
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Toward a better understanding of pancreatic ductal adenocarcinoma: glimmers of hope?
    Partensky C
    Pancreas; 2013 Jul; 42(5):729-39. PubMed ID: 23648843
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MiR-21, miR-34a, miR-198 and miR-217 as diagnostic and prognostic biomarkers for chronic pancreatitis and pancreatic ductal adenocarcinoma.
    Vychytilova-Faltejskova P; Kiss I; Klusova S; Hlavsa J; Prochazka V; Kala Z; Mazanec J; Hausnerova J; Kren L; Hermanova M; Lenz J; Karasek P; Vyzula R; Slaby O
    Diagn Pathol; 2015 Apr; 10():38. PubMed ID: 25908274
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A human cancer xenograft model utilizing normal pancreatic duct epithelial cells conditionally transformed with defined oncogenes.
    Inagawa Y; Yamada K; Yugawa T; Ohno S; Hiraoka N; Esaki M; Shibata T; Aoki K; Saya H; Kiyono T
    Carcinogenesis; 2014 Aug; 35(8):1840-6. PubMed ID: 24858378
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hereditary pancreatic cancer.
    Lynch HT; Brand RE; Deters CA; Shaw TG; Lynch JF
    Pancreatology; 2001; 1(5):466-71. PubMed ID: 12120226
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular diagnosis of early pancreatic ductal adenocarcinoma in high-risk patients.
    Wong T; Howes N; Threadgold J; Smart HL; Lombard MG; Gilmore I; Sutton R; Greenhalf W; Ellis I; Neoptolemos JP
    Pancreatology; 2001; 1(5):486-509. PubMed ID: 12120229
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of the DNA mismatch repair proteins (hMLH1 and hMSH2) in infiltrating pancreatic cancer and its relation to some phenotypic features.
    Tomaszewska R; Okoń K; Stachura J
    Pol J Pathol; 2003; 54(1):31-7. PubMed ID: 12817878
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pancreatic Cancer Genetics.
    Amundadottir LT
    Int J Biol Sci; 2016; 12(3):314-25. PubMed ID: 26929738
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular signaling in pancreatic ductal metaplasia: emerging biomarkers for detection and intervention of early pancreatic cancer.
    Li X; He J; Xie K
    Cell Oncol (Dordr); 2022 Apr; 45(2):201-225. PubMed ID: 35290607
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cellular and molecular aspects of pancreatic cancer.
    Gharibi A; Adamian Y; Kelber JA
    Acta Histochem; 2016 Apr; 118(3):305-16. PubMed ID: 26868366
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pancreatic cancer: translating lessons from mouse models and hereditary syndromes.
    Wescott MP; Rustgi AK
    Cancer Prev Res (Phila); 2008 Dec; 1(7):503-6. PubMed ID: 19138999
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.